Dehydratech

Despite this decline, gross profit for the quarter declined only 8% vs. year ago, clearly demonstrating the positive impact of the more profitable DehydraTECH licensing business on gross profit.

Lexaria’s DehydraTECH-Nicotine Faster than ZYN and on!

We are currently developing the platform for North American distribution around our rights to use Lexaria Bioscience Corp.’s ground-breaking DehydraTECH patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

The Company has already held discussions with certain laboratories that may be able to expand the number of prospective drugs using DehydraTECH under evaluation for coronavirus applications.